© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent


Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad

More articles/Ad

More articles

  • Kinnevik, the Swedish investment company, sold a 4.4% stake in German e-commerce company Zalando on Monday night with investors pouring into the trade after the US Federal Reserve boosted secondary markets.
  • China’s Genetron Holdings has launched bookbuilding for its Nasdaq listing, according to a source familiar with the matter.
  • Hygeia Healthcare Holdings has kicked off the roadshow for its up to HK$2.22bn ($286.4m) IPO, joining Hong Kong’s increasingly hot listing market.
  • CEE
    In GlobalMarkets’ discussion with DMO heads from Lithuania, Slovenia, Ukraine and Uzbekistan at the end of May, there emerged an optimistic outlook for their countries.
  • The coronavirus pandemic has catapulted capital markets forward in time. Things thought impossible have come about — above all, a sustained flow of credit through a harsh economic downturn. But are the markets heading for utopia or dystopia?
  • As part of the Global Borrowers & Bond Investors Forum Virtual 2020, GlobalCapital hosted a panel in May to discuss how supranationals’ businesses are changing during this crisis. The Covid-19 pandemic has meant vastly increased demands on their lending. The supranationals have had to drastically alter their plans and strategies to help their clients in fighting the virus, and in mitigating the economic consequences of global lockdown. That has meant that many of the panellists’ institutions will be turning to the capital markets for larger sums than they had anticipated. Of course, as is the case for so many, they are having to do so without the traditional comforts and conveniences of an office infrastructure — although this has caused less disruption and inefficiency than might have been expected.